Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis between US and European Populations
Abstract
Share and Cite
Thokagevistk, K.; Millier, A.; Lenert, L.; Sadikhov, S.; Moreno, S.; Toumi, M. Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis between US and European Populations. J. Mark. Access Health Policy 2016, 4, 30725. https://doi.org/10.3402/jmahp.v4.30725
Thokagevistk K, Millier A, Lenert L, Sadikhov S, Moreno S, Toumi M. Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis between US and European Populations. Journal of Market Access & Health Policy. 2016; 4(1):30725. https://doi.org/10.3402/jmahp.v4.30725
Chicago/Turabian StyleThokagevistk, Katia, Aurélie Millier, Leslie Lenert, Shamil Sadikhov, Santiago Moreno, and Mondher Toumi. 2016. "Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis between US and European Populations" Journal of Market Access & Health Policy 4, no. 1: 30725. https://doi.org/10.3402/jmahp.v4.30725
APA StyleThokagevistk, K., Millier, A., Lenert, L., Sadikhov, S., Moreno, S., & Toumi, M. (2016). Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis between US and European Populations. Journal of Market Access & Health Policy, 4(1), 30725. https://doi.org/10.3402/jmahp.v4.30725